Biocon Q2 net at Rs.162 crore

October 21, 2016 12:00 am | Updated December 02, 2016 10:39 am IST - BENGALURU:

Biocon reported a net profit of Rs.162 crore for the second quarter ended September 30, 2016 as against a loss of Rs.8 core in the same period last year.

The total revenue for the July-September period stood at Rs. 954 crore, registering a growth of 20 per cent, compared with the same period last year.

“Our performance in Q2 FY17, was led by strong growth across small molecules, biologics and research services. The expansion of our biologics footprint in emerging markets and licensing agreements boosted the revenue further,” said Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon.

“Our long term investments in R&D, manufacturing facility in Malaysia and clinical advancement of our programs will enable us to unlock greater value, going forward,” she added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.